After a cosmetic product hits the stores, however, "if the FDA
finds that it is not safe for consumers, we can take steps to have the product removed," says Katz.
In 1997, CSPI petitioned the FDA
to set rules for egg producers that would prevent contamination of their eggs with Salmonella bacteria.
agreed to withdraw a block they had placed on Crawford's nomination to head the FDA
after receiving assurances the agency would act on Plan B by Sept.
Congress responded by passing the Food, Drug, and Cosmetic Act of 1938--legislation that would vest the relatively new FDA
with far more power than it previously had.
According to FDA
Consumer, "In 1994, FDA
headquarters received approximately 200 reports of adverse reactions to cosmetics.
expanded the committee meeting from one to two days in response to pressure from the Society and people with MS because so many people wanted to voice their opinions about Tysabri.
Perhaps the FDA
could be replaced with private mechanisms, probably involving a much more active role for trial lawyers, a solution almost as unacceptable to free marketeers as regulatory agencies but at least a private and decentralized one.
Congressional investigations into whether the FDA
is truly living up to its responsibilities would help, but they're unlikely any time soon.
The incident prompted the FDA
to scrutinize the industry, and two years later, an FDA
task force recommended halting over-the-counter sales of such amino acids as L-tryptophan and other supplements with therapeutic qualities.
and its domestic tobacco company Philip Morris USA today reaffirmed their longstanding support for granting the Food and Drug Administration (FDA
) authority to effectively regulate tobacco products, and urged Congress to take quick action on the FDA
legislation sponsored by Senators Edward Kennedy (D-MA) and John Cornyn (R-TX), and Representatives Henry Waxman (D-CA) and Tom Davis (R-VA).
In addition to the guidance on pharmacogenomics data submissions (FDA
2003), the FDA
is embarking on a new guidance initiative for the co-development of pharmacogenomics-based drugs and biologic products and the diagnostic tests necessary for therapeutic decision making.
The doctor's shenanigans did him no good: FDA
barred him from running clinical drug trials after an audit revealed purported study patients who had never participated in the trial.